Frequent exacerbations of chronic obstructive pulmonary disease (COPD) have negative effects on quality of life and survival. Thus, factors related to exacerbations should be determined. We aimed to evaluate the effects of thyroid function on quality of life and exacerbation frequency in COPD patients.
1 February 2023 in Revista da Associação Médica Brasileira
Meteorological factors affect the respiratory system, and the most important factor is the change in ambient temperature and humidity. We aimed to investigate the seasonal characteristics of patients diagnosed with cryptogenic organizing pneumonia. The study included 84 cryptogenic organizing pneumonia, 55 chronic obstructive pulmonary disease, and 42 asthma patients. To determine the characteristics of the disease according to the seasons, the number of attacks and admissions was grouped according to the seasonal characteristics and analyzed for three groups. Among cryptogenic organizing pneumonia and chronic obstructive pulmonary disease patients, males significantly predominated (p<0.001). The hospitalization rate was highest in chronic obstructive pulmonary disease patients but similar to cryptogenic organizing pneumonia and asthma patients (p<0.001). The highest admission rate in cryptogenic organizing pneumonia patients was observed in spring (39.3% in spring, 26.2% in fall, 22.6% in winter, and 11.9% in summer). In winter, cryptogenic organizing pneumonia patients were admitted less frequently than chronic obstructive pulmonary disease and asthma patients. The neutrophil-to-lymphocyte ratio was higher in cryptogenic organizing pneumonia patients than in asthma patients and similar to chronic obstructive pulmonary disease patients. As a result of our study, the high rate of diagnosis and admission in the spring in cryptogenic organizing pneumonia suggested that the effect of allergens on the formation of cryptogenic organizing pneumonia should be investigated. In contrast, it should be kept in mind that cryptogenic organizing pneumonia may develop as a prolonged finding of involvement that may occur in the lung parenchyma due to lung infections and/or cold weather triggering during the winter months. In this regard, further studies can be conducted in which allergens and/or the history of infection in patients and meteorological variables are also evaluated.
Aim: To examine lipid profile and monocyte to high density lipoprotein ratio ratio (MHR) values in stable chronic obstructive pulmonary disease patients. Material and Method: Patients admitted to our hospital with the diagnosis of chronic obstructive pulmonary disease (COPD) between 01.01.2014 - 01.01.2020 were included in the study and evaluated retrospectively. According to the COPD guideline, two main groups were formed as A+B and C+D. Demographic characteristics, hemogram, C-Reaktif protein (CRP), albumin, lipid profile values were analyzed. Result: In our study, there were 360 cases, 293 (81.4%) of which were male. The mean age was 67.61±8.7 years. There were 162 cases (45%) in the A+B group and 198 (55%) in the C+D group.White blood cell (WBC) , neutrophil, lymphocyte, neutrophil/lymphocyte ratio (NLR), monocytes, hemoglobin, CRP, Albumin, high density lipoprotein (HDL), monocyte to HDL ratio (MHR) were found to be different at the level of statistical significance, while cholesterol, triglyceride and low density lipoprotein (LDL) were not at this level of significance. When evaluated with multivariate regression analysis afterwards, it was observed that the statistical significance levels of MHR, CRP and albumin values continued. Conclusion: We think that high MHR rate, high CRP, and low albumin values in stable COPD patients may be a stimulant for increased disease severity.
1 October 2013 in Multidisciplinary Respiratory Medicine
Background: Frequent exacerbations of chronic obstructive pulmonary disease (COPD) have negative effects on quality of life and survival. Thus, factors related to exacerbations should be determined. We aimed to evaluate the effects of thyroid function on quality of life and exacerbation frequency in COPD patients. Methods: The study population (n = 128) was divided into 3 groups (Group 1: COPD patients with hypothyroidism (n = 44); Group 2: COPD patients with normal thyroid function tests (n = 44); Group 3: Healthy subjects (n = 40)). Pulmonary function tests, maximum inspiratory pressure (MIP) and maximum expiratory pressure (MEP) measurements were performed. Quality of life questionnaire (Short Form 36, SF-36) was carried out. Patients were followed up for one year and number of exacerbations was recorded. Results: FVC, FEV1/FVC, and FEF 25–75% measurements were statistically different between group 1 and 2 (p = 0.041, p = 0.001, p = 0.009 respectively). Although MEP values were significantly different between group 1 and 2 (p = 0.006), there was no significant difference in MIP values between groups (p = 0.77). Quality of life scores in group 1 and 2 were significantly lower than control group. Exacerbation frequency was significantly higher in group 1 than in group 2 (p = 0.017). TSH values and exacerbation frequency had positive correlation (p < 0.0001; r = 0.82). Conclusions: The results of the present study suggest that thyroid function has an effect in exacerbation frequency of COPD. Decrease in exacerbation numbers with early detection of impairment in thyroid function will have positive contribution on quality of life in COPD patients.
Background: Small cell lung cancer (SCLC) is characterised by rapid growth, early dissemination and limited survival, underscoring the need for simple, reproducible prognostic markers. Inflammation-based indices derived from C-reactive protein (CRP) and albumin reflect systemic inflammatory and nutritional status, yet their relative prognostic performance in SCLC remains uncertain. Objective: To compare the prognostic impact of the Glasgow Prognostic Score (GPS), modified GPS (mGPS), and the CRP/albumin ratio (CAR) for overall survival (OS) and progression-free survival (PFS) in patients with SCLC. Methods: We retrospectively analysed 140 SCLC patients treated at a single centre between January 2014 and December 2024. GPS, mGPS and CAR were calculated from pre-treatment serum CRP and albumin. OS and PFS were estimated using Kaplan–Meier curves and compared with the log-rank test. Prognostic factors were evaluated using univariable and multivariable Cox regression, adjusting for age and disease stage. Results: Median OS and PFS for the cohort were 9.33 and 8.34 months respectively. Higher GPS and mGPS were associated with shorter OS and PFS (log-rank p<0.0001). Patients with high mGPS had shorter median OS than those with low mGPS (4.8 vs 10.8 months). CAR ≥0.60 (predefined threshold) was associated with poorer OS in univariable analysis, but CAR did not retain independent prognostic significance in multivariable models. GPS and mGPS remained independently associated with OS after adjustment (p<0.0001) Conclusions: Routine inflammation-based scores are closely linked to survival outcomes in SCLC. Among the evaluated indices, mGPS provided the most consistent stratification and may be a practical adjunct for baseline risk assessment; prospective multicentre validation is warranted.
Background and Objectives: Bronchiectasis exhibits heterogeneous inflammatory features. Although peripheral blood eosinophil counts guide therapy in other airway diseases, their role in phenotyping bronchiectasis remains under-defined. We investigated the clinical, microbiological, and inflammatory profiles of eosinopenic and eosinophilic phenotypes based on stable-state blood eosinophil counts. Materials and Methods: This retrospective cohort study evaluated 163 patients diagnosed with bronchiectasis between December 2020 and October 2024. Patients were stratified into three groups based on stable-state peripheral blood eosinophil counts: eosinopenia (≤100 cells/µL), intermediate eosinophil levels (101–299 cells/µL), and eosinophilia (≥300 cells/µL). Baseline demographics, comorbidities, laboratory data, sputum culture results, radiological scores, and clinical outcomes were compared. Factors associated with exacerbations were evaluated using multivariable logistic regression. Results: Eosinopenia was present in 30.1% of patients, intermediate eosinophil levels in 46.0%, and eosinophilia in 23.9%. Compared with patients in the intermediate group, those with eosinopenia had significantly higher sputum culture positivity (53.1% vs. 21.3%; p < 0.001), more frequent Pseudomonas aeruginosa isolation in stable-state sputum cultures (26.5% vs. 9.3%; p = 0.011), and a higher neutrophil-to-lymphocyte ratio. Hospitalization rates were numerically higher in the eosinophilia group than in the intermediate group (38.5% vs. 18.7%), although the overall between-group difference did not reach statistical significance (p = 0.069). In multivariable analysis, neither eosinopenia nor eosinophilia was significantly associated with exacerbation (adjusted OR 0.88, 95% CI 0.39–2.00; p = 0.760 and adjusted OR 1.51, 95% CI 0.56–4.07; p = 0.418, respectively). The modified Reiff score showed only a borderline association after adjustment (adjusted OR 1.16, 95% CI 0.99–1.35; p = 0.060). Conclusions: Blood eosinophil levels were associated with distinct clinical phenotypes in bronchiectasis. Eosinopenia was characterized by higher NLR and more frequent P. aeruginosa isolation in stable-state sputum cultures, whereas eosinophilia was associated with a distinct clinical profile. Blood eosinophil counts may serve as a practical phenotyping tool rather than a linear prognostic biomarker.